Peer Review reports
From: Integrated profiling identifies CACNG3 as a prognostic biomarker for patients with glioma
| Original Submission | ||
|---|---|---|
| 14 Sep 2022 | Submitted | Original manuscript |
| 15 Oct 2022 | Author responded | Author comments - Xianwen Li |
| Resubmission - Version 2 | ||
| 15 Oct 2022 | Submitted | Manuscript version 2 |
| 18 Oct 2022 | Author responded | Author comments - Xianwen Li |
| Resubmission - Version 3 | ||
| 18 Oct 2022 | Submitted | Manuscript version 3 |
| 13 Nov 2022 | Reviewed | Reviewer Report |
| 16 Jan 2023 | Reviewed | Reviewer Report |
| 30 Jan 2023 | Author responded | Author comments - Xianwen Li |
| Resubmission - Version 4 | ||
| 30 Jan 2023 | Submitted | Manuscript version 4 |
| 9 Feb 2023 | Author responded | Author comments - Xianwen Li |
| Resubmission - Version 5 | ||
| 9 Feb 2023 | Submitted | Manuscript version 5 |
| 10 Feb 2023 | Author responded | Author comments - Xianwen Li |
| Resubmission - Version 6 | ||
| 10 Feb 2023 | Submitted | Manuscript version 6 |
| 18 Feb 2023 | Author responded | Author comments - Xianwen Li |
| Resubmission - Version 7 | ||
| 18 Feb 2023 | Submitted | Manuscript version 7 |
| 6 Mar 2023 | Author responded | Author comments - Xianwen Li |
| Resubmission - Version 8 | ||
| 6 Mar 2023 | Submitted | Manuscript version 8 |
| 4 Apr 2023 | Author responded | Author comments - Xianwen Li |
| Resubmission - Version 9 | ||
| 4 Apr 2023 | Submitted | Manuscript version 9 |
| 27 Apr 2023 | Reviewed | Reviewer Report |
| Resubmission - Version 10 | ||
| Submitted | Manuscript version 10 | |
| Publishing | ||
| 27 Apr 2023 | Editorially accepted | |
| 11 Sep 2023 | Article published | 10.1186/s12885-023-10896-1 |
You can find further information about peer review here.